Theratechnologies was recognized as one of Canada’s Top Small and Medium Employers for 2022.

Employers are evaluated based on the below criteria:

• Physical Workplace;
• Work Atmosphere & Social;
• Health, Financial & Family Benefits;
• Vacation & Time Off;
• Employee Communications;
• Performance Management;
• Training & Skills Development; and
• Community Involvement.

Theratechnologies has been recognized as the 137th fastest growing Canadian companies over the last five years according to the 2019 Growth 500 ranking released by Canadian Business and Maclean’s.

The Growth 500 ranking is based on declared revenues over the last five completed fiscal years. For 2018, its last completed fiscal year, Theratechnologies reported revenues of CA$ 58,533,000 compared to revenues of CA$ 7,553,000 in fiscal year 2013. This represents a 675 percent growth over the last five completed fiscal years.

Theratechnologies ranked 21st on the first TSX30 ranking of top performers on the Toronto Stock Exchange.

The ranking was established based on the following criteria:

• Corporate operating business listed on TSX on June 30, 2019
• Listed on TSX for a minimum of 3 years or, if a TSXV graduate, a combination of TSX and TSXV for a minimum of 3 years with at least 1 year on TSX
• Closing dividend-adjusted share price of at least $0.50 on June 30, 2016
• Minimum market cap of $50 million on June 30, 2016

A total of 583 companies qualified for the 2019 TSX30 ranking. These companies were ranked based on 3-year share price performance from June 30, 2016 to June 30, 2019.

From June 30 2016 to June 30, 2019, Theratechnologies' stock price increased by 161%.

EY Entrepreneur Of The Year recognizes an impressive group of Quebec entrepreneurs for their financial performance, vision, leadership, personal integrity and entrepreneurial spirit.

Luc Tanguay, then President and CEO of Theratechnologies, was the recipient of the 2017 Quebec Life Sciences EY Entrepreneur of the Year Award.